Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Alpha-atrial Natriuretic Peptide, Human
2. Alpha-hanp
3. Alpha-human Atrial Natriuretic Peptide
4. Atrial Natriuretic Peptide Precusor A, Human
5. Natriuretic Peptide Precursor A, Human
6. Nppa Protein, Human
1. 89213-87-6
2. Alpha-atriopeptin
3. Sun-4936
4. Atrial Natriuretic Peptide
5. 85637-73-6
6. Atrial Natriuretic Peptide-28 (human Reduced)
7. Sun 4936
8. Atriopeptin
9. Alpha-human Atriopeptin
10. Atriopeptins
11. Cardionatrin
12. Atriopeptin-28 (human)
13. Alpha-atriopeptin (human)
14. Human Atriopeptin(1-28)
15. Auriculin (peptide)
16. Human Atriopeptin(99-126)
17. Ccris 4930
18. Atrial Natriuretic Peptide Human
19. Triopeptin (human Alpha-component)
20. Atrial Natriuretic Hormone
21. Atrial Natriuretic Peptides
22. Carperitide [usan:inn]
23. Alpha-human Atrial Natriuretic Hormone
24. Atrial Natriuretic Factor (99-126)
25. Natriuretic Peptides, Atrial
26. Atrial Natriuretic Peptide A
27. Unii-gz8fa500j0
28. Atrial Natriuretic Polypeptide
29. Alphahanf
30. Atrial Natriuretic Factor
31. Nppa Protein, Human
32. Anp 1-28,human
33. Schembl218549
34. Gz8fa500j0
35. Chembl2104386
36. Alpha-anf(1-28)-human
37. Chebi:135914
38. Dtxsid201346607
39. Bdbm50230986
40. Slrrsscfggrmdrigaqsglgcnsfry-oh
41. Atrial Natriuretic Peptide Carperitide
42. Akos024456845
43. Atriopeptin-33(rat), 1-de-l-leucine-2-de-l-alanine-3-deglycine-4-de-l-proline-5-de-l-arginine-17-l-methionine-
44. L-seryl-l-leucyl-l-arginyl-l-arginyl-l-seryl-l-seryl-l-cysteinyl-l-phenylalanylglycylglycyl-l-arginyl-l-methionyl-l-aspartyl-l-arginyl-l-isoleucylglycyl-l-alanyl-l-glutaminyl-l-serylglycyl-l-leucylglycyl-l-cysteinyl-l-asparaginyl-l-seryl-l-phenylalanyl-l-arginyl-l-tyrosine Cyclic(7->23)-disulfide
45. L-seryl-l-leucyl-l-arginyl-l-arginyl-l-seryl-l-seryl-l-cysteinyl-l-phenylalanylglycylglycyl-l-arginyl-l-methionyl-l-aspartyl-l-arginyl-l-isoleucylglycyl-l-alanyl-l-glutaminyl-l-serylglycyl-l-leucylglycyl-l-cysteinyl-l-asparaginyl-l-seryl-l-phenylalanyl-l-arginyl-l-tyrosine Cyclic(7-23)-disulfide
46. Atrial Natriuretic Factor (1-28) (human)
47. Atrial Natriuretic Peptide (1-28) (human, Porcine)
48. H-ser-leu-arg-arg-ser-ser-cys-phe-gly-gly-arg-met-asp-arg-ile-gly-ala-gln-ser-gly-leu-gly-cys-asn-ser-phe-arg-tyr-oh
Molecular Weight | 3080.5 g/mol |
---|---|
Molecular Formula | C127H203N45O39S3 |
XLogP3 | -14.9 |
Hydrogen Bond Donor Count | 53 |
Hydrogen Bond Acceptor Count | 48 |
Rotatable Bond Count | 75 |
Exact Mass | 3079.4480502 g/mol |
Monoisotopic Mass | 3078.4446953 g/mol |
Topological Polar Surface Area | 1480 Ų |
Heavy Atom Count | 214 |
Formal Charge | 0 |
Complexity | 6940 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 24 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
72
PharmaCompass offers a list of Carperitide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Carperitide manufacturer or Carperitide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Carperitide manufacturer or Carperitide supplier.
PharmaCompass also assists you with knowing the Carperitide API Price utilized in the formulation of products. Carperitide API Price is not always fixed or binding as the Carperitide Price is obtained through a variety of data sources. The Carperitide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A alpha-atrial natriuretic peptide, human manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of alpha-atrial natriuretic peptide, human, including repackagers and relabelers. The FDA regulates alpha-atrial natriuretic peptide, human manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. alpha-atrial natriuretic peptide, human API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of alpha-atrial natriuretic peptide, human manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A alpha-atrial natriuretic peptide, human supplier is an individual or a company that provides alpha-atrial natriuretic peptide, human active pharmaceutical ingredient (API) or alpha-atrial natriuretic peptide, human finished formulations upon request. The alpha-atrial natriuretic peptide, human suppliers may include alpha-atrial natriuretic peptide, human API manufacturers, exporters, distributors and traders.
click here to find a list of alpha-atrial natriuretic peptide, human suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A alpha-atrial natriuretic peptide, human DMF (Drug Master File) is a document detailing the whole manufacturing process of alpha-atrial natriuretic peptide, human active pharmaceutical ingredient (API) in detail. Different forms of alpha-atrial natriuretic peptide, human DMFs exist exist since differing nations have different regulations, such as alpha-atrial natriuretic peptide, human USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A alpha-atrial natriuretic peptide, human DMF submitted to regulatory agencies in the US is known as a USDMF. alpha-atrial natriuretic peptide, human USDMF includes data on alpha-atrial natriuretic peptide, human's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The alpha-atrial natriuretic peptide, human USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of alpha-atrial natriuretic peptide, human suppliers with USDMF on PharmaCompass.
alpha-atrial natriuretic peptide, human Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of alpha-atrial natriuretic peptide, human GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right alpha-atrial natriuretic peptide, human GMP manufacturer or alpha-atrial natriuretic peptide, human GMP API supplier for your needs.
A alpha-atrial natriuretic peptide, human CoA (Certificate of Analysis) is a formal document that attests to alpha-atrial natriuretic peptide, human's compliance with alpha-atrial natriuretic peptide, human specifications and serves as a tool for batch-level quality control.
alpha-atrial natriuretic peptide, human CoA mostly includes findings from lab analyses of a specific batch. For each alpha-atrial natriuretic peptide, human CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
alpha-atrial natriuretic peptide, human may be tested according to a variety of international standards, such as European Pharmacopoeia (alpha-atrial natriuretic peptide, human EP), alpha-atrial natriuretic peptide, human JP (Japanese Pharmacopeia) and the US Pharmacopoeia (alpha-atrial natriuretic peptide, human USP).